Clinical Trial Update: Safety of Autologous MSC Infusion to Treat Epilepsy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the safety of autologous mesenchymal stem cell infusion for epilepsy (Phase 1/Phase 2 completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• autologous mesenchymal stem cell infusion (mesenchymal stem cells (autologous))

Snippet

Sponsor: Ministry of Public Health, Republic of Belarus | Conditions: Epilepsy | Phase 1, Phase 2 | Status: COMPLETED